Skip to main content

Published locations for Azacitidine plus enasidenib improves response, but not survival, in mIDH2 AML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Azacitidine plus enasidenib improves response, but not survival, in mIDH2 AML

User login

  • Reset your password
  • /content/azacitidine-plus-enasidenib-improves-response-not-survival-midh2-aml
  • /hematologynews/article/224456/aml/azacitidine-plus-enasidenib-improves-response-not-survival-midh2
  • /internalmedicinenews/article/224456/aml/azacitidine-plus-enasidenib-improves-response-not-survival
  • /oncologypractice/article/224456/aml/azacitidine-plus-enasidenib-improves-response-not-survival-midh2
  • /hematology-oncology/article/224456/aml/azacitidine-plus-enasidenib-improves-response-not-survival
  • /internalmedicine/article/224456/aml/azacitidine-plus-enasidenib-improves-response-not-survival-midh2